Kilitch Drugs P/E Ratio

Current P/E Ratio

25.69

High Valuation

High - Growth expectations or overvalued

Kilitch Drugs P/E ratio. Kilitch Drugs (KILITCH) P/E ratio is 25.69 (High), EPS (TTM) ₹8.91, current price ₹233.74 on NSE vs historical average P/E of 37.23 (40.0th percentile) — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see Kilitch Drugs screener.

Current Valuation Metrics

P/E Ratio 25.69

Current Price ₹233.74

EPS (TTM) ₹8.91

Exchange NSE

Valuation Signal

Signal Overvalued

Historical Avg 37.23

Historical Range 22.44 - 73.69

Percentile 40.0%

Sector Context

Sector Average 56.35

Sector Median 32.5

Sector Rank #11 of 199

Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹16.51

Mar 2026 ₹4.24

Jun 2026 ₹0.83

KILITCH P/E Ratio — Valuation Signal & Historical Context

Kilitch Drugs P/E 25.69 vs historical average 37.23, range 22.44–73.69 — signal: Overvalued. Also explore KILITCH share price charts to track price trends across different timeframes.

Stock appears overvalued with PE of 25.69, suggesting caution for new investments
Current PE is 31.0% below historical average
Trading at discount to sector average PE of 56.35

Kilitch Drugs P/E Ratio Historical Trend

KILITCH annual price-to-earnings ratio — 5 years, EPS and year-end price. Current P/E 25.69 vs historical average 37.23. Examine KILITCH Q4 results for recent quarterly revenue, profit and EPS trends.

KILITCH Historical P/E Ratio — EPS, Year-End Price & Valuation

Kilitch Drugs annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year	P/E Ratio	EPS (₹)	Year-end Price (₹)	Exchange	Valuation
2025	22.44	15.82	₹355.00	NSE	Moderate
2024	26.23	12.14	₹318.40	BSE	High
2023	39.46	9.22	₹363.80	BSE	High
2022	24.31	6.28	₹152.65	BSE	Moderate
2021	73.69	3.33	₹245.40	BSE	High

KILITCH vs Healthcare Peers — P/E Ratio Comparison

Kilitch Drugs P/E 25.69 vs Healthcare average 56.35, median 32.5 — range 2.04–740.29.

Sector Average

56.35

Sector Median

32.5

Lowest P/E

2.04

Highest P/E

740.29

Companies

199

Company	Symbol	P/E Ratio	Market Cap (₹ Cr)	Valuation
Sunrest Lifescience	SUNREST	2.04	₹65	Low
Murae Organisor	MURAE	2.86	₹41	Low
Phaarmasia	PHRMASI	3.41	₹63	Low
Sun Pharma Advanced Rese…	SPARC	3.98	₹6,206	Low
Dipna Pharmachem	DPL	4.57	₹12	Low
JFL Life Sciences	JFLLIFE	4.88	₹66	Low
GKB Ophthalmics	GKB	5.88	₹32	Low
Kabra Drugs	KABRADG	6.09	₹44	Low
Royal Sense	ROYAL	6.58	₹47	Low
Colinz Laboratories	COLINZ	6.62	₹18	Low